Abstract
A novel, simple and stability indicating reverse-phase high performance liquid chromatographic method with UV detection at 220 nm (RP-HPLC-UV) was established to realize the simultaneous analysis of carbetocin and ten related impurities. This paper performed the most comprehensive impurity profiling of carbetocin, including the synthesis-related impurities, the isomers of carbetocin and the degradants formed from the forced degradation research, the structures of which were tentatively identified by a two-dimensional liquid chromatography-mass spectrometry technology. The novelty of this RP-HPLC-UV method was demonstrated by its satisfactory resolution and selectivity, which was achieved using an YMC-pack C18 column kept at 40 ℃, and optimal organic modifier gradient. The mobile phase A was potassium dihydrogen phosphate buffer (pH 6.5)—acetonitrile (80:20, v/v), and the mobile phase B was potassium dihydrogen phosphate buffer (pH 6.5)—acetonitrile (72:28, v/v). The forced degradation research proved the stability-indicating capacity of the method and validation study was performed according to ICH requirements. In summary, this RP-HPLC-UV method could support the simultaneous determination of related substances of carbetocin in bulk drug and in pharmaceutical formulations.
Similar content being viewed by others
Data availability
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Code availability
Not applicable.
References
Su LL, Chong Y-S, Samuel M (2012) Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005457.pub3
Thomas Engstrøm TB, Melin P, Vilhardt H (1998) Oxytocin receptor binding and uterotonic activity of carbetocin and its metabolites following enzymatic degradation. Eur J Pharm 355(2–3):203–210. https://doi.org/10.1016/S0014-2999(98)00513-5
Klenerova VKI, Sida P, Hlinak Z, Hynie S (2009) Oxytocin and carbetocin effects on spontaneous behavior of male rats: modulation by oxytocin receptor antagonists. Neuro Endocrinol Lett 30(3):335–342
Hunter DJS, Schulz P, Wassenaar W (1992) Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther 52(1):60–67. https://doi.org/10.1038/clpt.1992.103
Gazis D (1978) Plasma half-lives of vasopressin and oxytocin analogs after iv injection in rats. Proc Soc Exp Biol Med 158(4):663–665. https://doi.org/10.3181/00379727-158-40269
Gazis DSWH (1978) Elimination of infused arginine-vasopressin and its long-acting deaminated analogue in rats. J Endocrinol 78(2):179–186. https://doi.org/10.1677/joe.0.0780179
Filippi V, Chou D, Ronsmans C, Graham W, Say L (2016) Levels and causes of maternal mortality and morbidity. Trop Med Int Health 7(6):499–505. https://doi.org/10.1596/978-1-4648-0348-2_ch3
Sanz-Nebot V, Garcés A, Barbosa J (1999) Investigation of crudes of synthesis of carbetocin by liquid chromatography coupled to electrospray ionization mass spectrometry. J Chromatogr A 833(2):267–275. https://doi.org/10.1016/S0021-9673(98)01053-X
Sanz-Nebot V, Toro I, Garcés A, Barbosa J (1999) Separation and identification of peptide mixtures in a synthesis crude of carbetocin by liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom 13(23):2341–2347. https://doi.org/10.1002/(SICI)1097-0231(19991215)13:23%3c2341::AID-RCM795%3e3.0.CO;2-9
Zhang H, Yang HX, Liang CG, Li J (2007) HPLC analysis of carbetocin and its related impurities. Chin J Pharm Anal 27(10):1553–1555. https://doi.org/10.16155/j.0254-1793.2007.10.028
Malm M, Madsen I, Kjellström J (2018) Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries. J Pept Sci 24(6):e3082. https://doi.org/10.1002/psc.3082
International conference on harmonization February (2003) Stability testing of new drug substances and products Q1A(R2)
International conference on harmonization November (2005) Validation of analytical procedures: text and methodology Q2(R1)
International conference on harmonization June (2006) Guideline on impurities in Drug Products Q3B(R2)
Henzel WJ, Stults JT (2001) Reversed-phase isolation of peptides. Curr Protoc Protein Sci. https://doi.org/10.1002/0471140864.ps1106s24
Fekete S, Veuthey J-L, Guillarme D (2012) New trends in reversed-phase liquid chromatographic separations of therapeutic peptides and proteins: theory and applications. J Pharm Biomed Anal 69:9–27. https://doi.org/10.1016/j.jpba.2012.03.024
Sanz-Nebot V, Benavente F, Toro I, Barbosa J (2001) Optimization of HPLC conditions for the separation of complex crude mixtures produced in the synthesis of therapeutic peptide hormones. Chromatographia 53(1):S167–S173. https://doi.org/10.1007/BF02490324
Gilar M, Olivova P, Daly AE, Gebler JC (2015) Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions. J Sep Sci 28(14):1694–1703. https://doi.org/10.1002/jssc.200500116
Molnár I, Horváth C (1977) Separation of amino acids and peptides on non-polar stationary phases by high-performance liquid chromatography. J Chromatogr 142:623–640. https://doi.org/10.1016/S0021-9673(01)92073-4
Macnair JE, Patel KD, Jorgenson JW (1999) Ultrahigh-pressure reversed-phase capillary liquid chromatography: isocratic and gradient elution using columns packed with 1.0-micron particles. Anal Chem 71(3):700–708. https://doi.org/10.1021/ac9807013
Ehab Ibrahim A, Elhenawee M, Saleh H (2020) Monolithic and core-shell particles stationary phase morphologies in protein analysis; peptide mapping of erythropoietin hormone and determination of carbetocin. Ann Pharm Fr 78(3):206–216. https://doi.org/10.1016/j.pharma.2020.01.008
Clifford Y, Podtelejnikov AV, Michael LN (2017) Improved reversed phase chromatography of hydrophilic peptides from spatial and temporal changes in column temperature. J Proteome Res 16(6):2307–2317. https://doi.org/10.1021/acs.jproteome.6b01055
Krishnaiah C, Vishnu Murthy M, Kumar R, Mukkanti K (2011) Development of a stability-indicating UPLC method for determining olanzapine and its associated degradation products present in active pharmaceutical ingredients and pharmaceutical dosage forms. J Pharm Biomed Anal 54(4):667–673. https://doi.org/10.1016/j.jpba.2019.112808
Wang C, Dong H, Liu H, Sun Z, Yuan A, Wu J, Hu Y (2020) Using HPLC to analyze (S)-oxiracetam and four related substances in the bulk drug of (S)-oxiracetam. J Pharm Biomed Anal. https://doi.org/10.1016/j.jpba.2019.113072
Bianchini RM, Castellano PM, Kaufman TS (2009) Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs. Anal Chim Acta 654(2):141–147. https://doi.org/10.1016/j.aca.2009.09.022
Vojta J, Jedlicka A, Coufal P, Janeckova L (2015) A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form. J Pharm Biomed Anal 109:36–44. https://doi.org/10.1016/j.jpba.2015.01.059
Acknowledgements
This paper was supported by National Natural Science Foundation of China (No. 31872755, 81872811), Jiangsu Outstanding Youth Funding (BK20190007) and the Central Fundamental Research Funds for the Central Universities (02141438473).
Funding
National Natural Science Foundation of China (No. 31872755, 81872811); Jiangsu Outstanding Youth Funding (BK20190007); Central Fundamental Research Funds for the Central Universities (02141438473).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
None.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yin, L., Huang, Y., Wang, C. et al. Development of a Novel and Stability Indicating RP-HPLC-UV Method for Simultaneous Analysis of Carbetocin and Ten Impurities in Carbetocin Injection Products. Chromatographia 84, 967–978 (2021). https://doi.org/10.1007/s10337-021-04083-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-021-04083-2